Korean J Thorac Cardiovasc Surg.
1999 Jul;32(7):603-612.
Cardioprotective Effect of Calcium Preconditioning and Its Relation
to Protein Kinase C in Isolated Perfused Rabbit Heart
- Affiliations
-
- 1Department of Chest Surgery, College of Medicine, Chung-Ang University.
- 2Department of Histology, College of Medicine, Chung-Ang University.
Abstract
-
BACKGROUND: It has been documented that brief repetitive periods of ischemia and reperfusion
(ischemic preconditioning, IP) enhances the recovery of post-ischemic contractile function
and reduces infarct size after a longer period of ischemia. Many mechanisms have been proposed
to explain this process. Recent studies have suggested that transient increase in the
intracellular calcium may have triggered the activation of protein kinase C(PKC); however,
there are still many controversies. Accordingly, the author performed the present study to
test the hypothesis that preconditioning with high concentration of calcium before sustained
subsequent ischemia(calcium preconditioning) mimics IP by PKC activation.
MATERIAL AND METHOD: The isolated hearts from the New Zealand White rabbits(1.5~2.0 kg body
weight) METHOD: The isolated hearts from the New Zealand White rabbits(1.5~2.0 kg body weight)
were perfused with Tyrode solution by Langendorff technique. After stabilization of baseline
hemodynamics, the hearts were subjected to 45-minute global ischemia followed by a 120-minute
reperfusion with IP(IP group, n=13) or without IP(ischemic control, n=10). IP was induced by
single episode of 5-minute global ischemia and 10-minute reperfusion. In the Ca2+
preconditioned group, perfusate containing 10(n=10) or 20 mM(n=11) CaCl2 was perfused
for 10 minutes after 5-minute ischemia followed by a 45-minute global ischemia and
a 120-minute reperfusion. Baseline PKC was measured after 50-minute perfusion without
any treatment(n=5). Left ventricular function including developed pressure(LVDP), dP/dt,
heart rate, left ventricular end-diastolic pressure(LVEDP) and coronary flow(CF) was measured.
Myo car ial cytosolic and membrane PKC activities were measured by 32P-gamma-ATP incorporation
into PKC-specific pepetide. The infarct size was determined using the TTC (tetrazolium salt)
staining and planimetry. Data were analyzed using one-way analysis of variance(ANOVA)
variance(ANOVA) and Tukey's post-hoc test.
RESULT: IP increased the functional recovery including LVDP, dP/dt and CF(p<0.05) and
lowered the ascending range of LVEDP(p<0.05); it also reduced the infarct size from 38%
to 20%(p<0.05). In both of the Ca2+ preconditioned group, functional recovery was not
significantly different in comparison with the ischemic control, however, the infarct size
was reduced to 19~23%(p<0.05). In comparison with the baseline(7.31 0.31 nmol/g tissue),
the activities of the cytosolic PKC tended to decrease in both the IP and Ca2+ preconditioned
groups, particularly in the 10 mM Ca2+ preconditioned group(4.19 0.39 nmol/g tissue, p<0.01);
the activity of membrane PKC was significantly increased in both IP and 10 mM Ca2+
preconditioned group (p<0.05; 1.84 0.21, 4.00 0.14, and 4.02 0.70 nmol/g tissue in
the baseline, IP, and 10 mM Ca2+ preconditioned group, respectively). However, the activity
of both PKC fractions were not significantly different between the baseline and the ischemic
control.
CONCLUSION
These results indicate that in isolated Langendorff-perfused rabbit heart model,
calcium preconditioning with high concentration of calcium does not improve post-ischemic
functional recovery. However, it does have an effect of limiting(reducing) the infart size
by ischemic preconditioning, and this cardioprotective effect, at least in part, may have
resulted from the activation of PKC by calcium which acts as a messenger(or trigger) to
activate membrane PKC.